LDS/Medical Tests/Multi Gene Methylation Assay for Hepatocellular Carcinoma by NGS (HelioLiver™, HelioHCC™ Trace, EarlyDx MethylScan™)

Multi Gene Methylation Assay for Hepatocellular Carcinoma by NGS (HelioLiver™, HelioHCC™ Trace, EarlyDx MethylScan™)

Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide and a leading cause of cancer-related deaths. It is important to diagnose HCC at an early stage to enhance patient prognosis. However, the early diagnosis of HCC is challenged by a lack of non-invasive biomarkers. Alpha-Fetoprotein (AFP) is the only accepted blood-based marker for HCC and abnormal levels are typically only detected after considerable tumor progression. Recently, tests to identify circulating tumor DNA released into the blood as a result of tumor cell necrosis and apoptosis in blood have been developed to overcome this limitation.

The HelioLiver™ detects HCC-specific methylation patterns in circulating DNA (ctDNA) which are felt to be predictive of HCC. The HelioLiver™ test may be useful but is not recommended by any society in screening for HCC including patients with risk factors such as: cirrhosis, non-alcoholic fatty liver disease (NAFLD), chronic viral hepatitis (Hepatitis B, C or D), hereditary hemochromatosis, alpha-1-antitrypsin deficiency, and acute intermittent porphyria.

EarlyDx’s MethylScan™ test analyzes DNA methylation patterns in cell-free DNA (cfDNA) circulating in the bloodstream, offering an assessment of liver health from a single blood draw. Using deep learning, MethylScan™ HCC can detect hepatocellular carcinoma at early stages in the at-risk population with high sensitivity and specificity.

  • Useful for early detection of hepatocellular carcinoma in patients at risk
  • Useful in selection and monitoring response to therapy
A normal methylation pattern indicated a low risk of HCC whereas abnormal patterns indicate a high risk of incidence or recurrence of HCC.

Normal methylation pattern

Next-generation sequencing (NGS).

Plasma (ACD, or EDTA). 

Alternative specimen: isolated cfDNA. 

Stability

  • Ambient: 4 hrs.
  • Refrigerated: 24 hrs.
AFP, AFP-L3, GALAD score, liver biopsy, bilirubin (total and direct), AST, ALT, albumin, ALP, gamma-GT.
3-7 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login